Skip to content
Review Open access

Genetic data sharing by clinical laboratories in Canada: A position statement by the Canadian College of Medical Geneticists.

Sep 2026 · American Journal of Human Genetics · 0 citations · 40 references
Medicine

TL;DR

National guidance to support secure, ethical, and effective genetic data sharing by Canadian clinical laboratories is developed and aims to align Canadian clinical laboratory data-sharing practices with international standards and improve diagnostic accuracy, equity, and innovation in genomic medicine.

Abstract

Next-generation sequencing has transformed diagnosis, prognosis, and treatment across rare disease, cancer, immunology, and infectious disease. As variant interpretation may evolve with emerging evidence, sharing genetic data is essential to improve diagnostic accuracy and advance genomic medicine. However, practical guidance for implementing clinical genetic data sharing remains limited. The Canadian College of Medical Geneticists (CCMG), therefore, developed national guidance to support secure, ethical, and effective genetic data sharing by Canadian clinical laboratories. An ad hoc CCMG working group with broad geographic and disciplinary representation developed the initial framework of this guidance through six meetings. Members included clinical laboratory geneticists, genomics specialists, a legal expert, a clinical geneticist, and a genetic counselor. The process drew on expert consensus (including patient and family perspectives), existing frameworks, and relevant peer-reviewed evidence, followed by iterative external review. Reporting was informed by the Appraisal of Guidelines for Research and Evaluation II (AGREE II) framework. The guidance provides recommendations to support genetic data sharing by Canadian clinical laboratories. It addresses benefits, risks, and ethical considerations, with emphasis on proportionality, privacy, and governance. Recommendations include approaches to sharing diverse genetic data types, establishing institutional policies, and addressing implementation barriers. This guidance aims to align Canadian clinical laboratory data-sharing practices with international standards and improve diagnostic accuracy, equity, and innovation in genomic medicine. By emphasizing ethical principles, proportionality, and governance, it seeks to enable responsible data sharing; strengthen trust among patients, families, and professionals; and contribute to the broader global genomic data ecosystem.

Read PDF

Similar papers

Conference Open access 2026

Clinical Genomic Sequence Data Sharing for Precision Medicine: A Scoping Review of Technologies, Standards, Challenges, and Future Directions

This review explores current methods, technologies and governance structures for the sharing of genomic data, as well as national genome initiatives and the genomics industry to offer a broad overview and proposes four recommendations for future directions to improve the consistency, security and interoperability of da...

Ekta Maini, Dhairya Marwaha, Dheeraj Marwaha · 0 citations
Open access Oct 2026

CO-04 | INTEGRATING EXPERTISE: IMPLEMENTATION OF A MULTIDISCIPLINARY PATHWAY FOR GENETIC TESTING AND COUNSELLING IN INHERITED BLEEDING DISORDERS

A multidisciplinary pathway for genetic testing and counselling in IBDs and preliminary results from its implementation in a single center are described to highlight the value of a structured approach to genetic testing and counselling.

Eliana Zacchi · 0 citations
Review Open access Oct 2026

Genetic Testing: Basic Principles for the Pediatrician

Current genetic testing modalities available for pediatricians are described, guidance on test selection and result interpretation is provided, and providers are informed on proper genetic testing consent practices are informed.

Jonathan B. Trapani, John A. Phillips, Scott K. Ward · 0 citations
Review Open access Sep 2026

A Standardized Framework to Assess the Clinical Actionability of Genes and Associated Conditions for Population-Based Genomic Screening

Abstract Introduction As population-based genomic screening (PGS) programs are increasingly implemented, standardized, evidence-based approaches are needed to support decision-making about which genetic findings should be returned based on clinical actionability. The Clinical Genome Resource (ClinGen) Actionability Fra...

J. Hunter, C. Allen, J. S. Berg et al. · 0 citations
Open access Sep 2026

Caring for Rare Genetic Disease: A Vision for the Future

It is argued that the value of genomic medicine for rare disease should be assessed beyond diagnostic yield alone and across individual, clinical and societal levels.

R. Horn, Sarah L. Wynn, S. Houge · 0 citations
Open access Oct 2026

Position Statement on the Regulation of Genetic Counselors in Canada on Behalf of National and Provincial Genetic Counselor Organizations

All national and provincial Canadian GC organizations endorse the need for regulatory oversight across Canadian provinces and territories and recommend that the Canadian Certified Genetic Counsellor/Conseiller en génétique agréé(e) du Canada (CGAC) credential be adopted as the standard for assessing competence.

R. Vanneste, A. Secord, Diane Myles-Reid et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.